CTLA4 and periodontitis: Inflammation of the oral mucosa manifesting as nonspecific stomatitis, periodontitis, and lichenoid reaction is relatively common and, in fact, better documented under treatment with PD-1/PD-L1 inhibitors, as opposed to CTLA-4 inhibitors [34,77,78].